JP2023550653A5 - - Google Patents
Info
- Publication number
- JP2023550653A5 JP2023550653A5 JP2023531564A JP2023531564A JP2023550653A5 JP 2023550653 A5 JP2023550653 A5 JP 2023550653A5 JP 2023531564 A JP2023531564 A JP 2023531564A JP 2023531564 A JP2023531564 A JP 2023531564A JP 2023550653 A5 JP2023550653 A5 JP 2023550653A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- pharmaceutically acceptable
- acceptable salt
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026063851A JP2026120631A (ja) | 2020-11-25 | 2026-04-08 | Ｃｎｓの障害を治療するための組成物及び方法 |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063118079P | 2020-11-25 | 2020-11-25 | |
| US202063118086P | 2020-11-25 | 2020-11-25 | |
| US202063118092P | 2020-11-25 | 2020-11-25 | |
| US202063118122P | 2020-11-25 | 2020-11-25 | |
| US202063118107P | 2020-11-25 | 2020-11-25 | |
| US202063118089P | 2020-11-25 | 2020-11-25 | |
| US63/118,107 | 2020-11-25 | ||
| US63/118,086 | 2020-11-25 | ||
| US63/118,092 | 2020-11-25 | ||
| US63/118,079 | 2020-11-25 | ||
| US63/118,122 | 2020-11-25 | ||
| US63/118,089 | 2020-11-25 | ||
| PCT/US2021/060358 WO2022115381A1 (en) | 2020-11-25 | 2021-11-22 | Compositions and methods for treating cns disorders cross reference to related application |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026063851A Division JP2026120631A (ja) | 2020-11-25 | 2026-04-08 | Ｃｎｓの障害を治療するための組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550653A JP2023550653A (ja) | 2023-12-04 |
| JP2023550653A5 true JP2023550653A5 (enExample) | 2026-04-16 |
Family
ID=78957246
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023531564A Pending JP2023550653A (ja) | 2020-11-25 | 2021-11-22 | Ｃｎｓの障害を治療するための組成物及び方法 |
| JP2026063851A Pending JP2026120631A (ja) | 2020-11-25 | 2026-04-08 | Ｃｎｓの障害を治療するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026063851A Pending JP2026120631A (ja) | 2020-11-25 | 2026-04-08 | Ｃｎｓの障害を治療するための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240101592A1 (enExample) |
| EP (1) | EP4251634A1 (enExample) |
| JP (2) | JP2023550653A (enExample) |
| KR (1) | KR20230124916A (enExample) |
| AU (1) | AU2021385335A1 (enExample) |
| CA (1) | CA3202870A1 (enExample) |
| IL (1) | IL303101A (enExample) |
| MX (1) | MX2023006063A (enExample) |
| TW (1) | TW202235089A (enExample) |
| WO (1) | WO2022115381A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS62761B1 (sr) | 2012-08-21 | 2022-01-31 | Sage Therapeutics Inc | Alopregnanolon za lečenje refraktornog epileptičkog statusa |
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| WO2018013613A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| US20200291059A1 (en) | 2017-12-08 | 2020-09-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| JP7787635B2 (ja) * | 2019-06-27 | 2025-12-17 | セージ セラピューティクス， エルエルシー | Ｃｎｓ障害を治療するための組成物及び方法 |
| JP2026516023A (ja) * | 2023-05-11 | 2026-05-19 | シューチン バイオファーマ カンパニー リミテッド | ステロイド系化合物、製造方法及びその使用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2453823C2 (de) * | 1974-11-11 | 1984-08-09 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11β,17α-Dihydroxy-15α,16α-methylen-1,4-pregnadien-3,20-dion |
| DD122520A1 (enExample) * | 1975-07-16 | 1976-10-12 | ||
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| US12139508B2 (en) * | 2018-02-11 | 2024-11-12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Steroid derivative regulators, method for preparing the same, and uses thereof |
| MX2020008182A (es) * | 2018-02-11 | 2020-09-22 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Reguladores de derivados esteroides, metodo para prepararlos y usos de los mismos. |
| WO2021023213A1 (zh) * | 2019-08-07 | 2021-02-11 | 上海翰森生物医药科技有限公司 | 一种甾族类衍生物调节剂的盐及其晶型 |
| CN115551514A (zh) * | 2020-03-25 | 2022-12-30 | 萨奇治疗股份有限公司 | 用于治疗呼吸系统病症的药物的用途 |
-
2021
- 2021-11-22 EP EP21827547.7A patent/EP4251634A1/en active Pending
- 2021-11-22 AU AU2021385335A patent/AU2021385335A1/en active Pending
- 2021-11-22 KR KR1020237020928A patent/KR20230124916A/ko not_active Withdrawn
- 2021-11-22 WO PCT/US2021/060358 patent/WO2022115381A1/en not_active Ceased
- 2021-11-22 IL IL303101A patent/IL303101A/en unknown
- 2021-11-22 US US18/254,209 patent/US20240101592A1/en active Pending
- 2021-11-22 CA CA3202870A patent/CA3202870A1/en active Pending
- 2021-11-22 JP JP2023531564A patent/JP2023550653A/ja active Pending
- 2021-11-22 MX MX2023006063A patent/MX2023006063A/es unknown
- 2021-11-25 TW TW110144001A patent/TW202235089A/zh unknown
-
2026
- 2026-04-08 JP JP2026063851A patent/JP2026120631A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101472900B (zh) | 多发性硬化症的治疗或预防药 | |
| AU2009294558B2 (en) | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them | |
| JP2022510683A5 (enExample) | ||
| JP2023119042A5 (enExample) | ||
| JP2021510695A5 (enExample) | ||
| JP2022534424A5 (enExample) | ||
| JP2019520417A5 (enExample) | ||
| CN110799509A (zh) | Pd-1/pd-l1抑制剂 | |
| JP2013531006A5 (enExample) | ||
| JP2025071130A5 (enExample) | ||
| JP2022538301A5 (enExample) | ||
| JP2023518411A5 (enExample) | ||
| JP2018517746A5 (enExample) | ||
| JP2013535460A5 (enExample) | ||
| JP2007500720A5 (enExample) | ||
| RU2012125372A (ru) | Производные пиразола в качестве ингибиторов 11-бета-hsd1 | |
| JP2004532894A5 (enExample) | ||
| JP2017526724A5 (enExample) | ||
| JP2022550353A5 (enExample) | ||
| JP2022522890A5 (enExample) | ||
| JP2023538159A5 (enExample) | ||
| JP2021529186A (ja) | Ｎｌｒｐ調節剤 | |
| RU2016116243A (ru) | Ингибиторы цистеинпротеаз катепсинов | |
| RU2003118718A (ru) | Производные дигидронафталина и лекарственное средство, включающее указанные производные в качестве активного ингредиента | |
| KR101250889B1 (ko) | 글리신 유도체 및 그 용도 |